Follow-up after gastrectomy for cancer: The Charter Scaligero Consensus Conference Journal Article


Authors: Baiocchi, G. L.; D'Ugo, D.; Coit, D.; Hardwick, R.; Kassab, P.; Nashimoto, A.; Marrelli, D.; Allum, W.; Berruti, A.; Chandramohan, S. M.; Coburn, N.; Gonzàlez-Moreno, S.; Hoelscher, A.; Jansen, E.; Leja, M.; Mariette, C.; Meyer, H. J.; Mönig, S.; Morgagni, P.; Ott, K.; Preston, S.; Rha, S. Y.; Roviello, F.; Sano, T.; Sasako, M.; Shimada, H.; Schuhmacher, C.; So Bok-yan, J.; Strong, V.; Yoshikawa, T.; Terashima, M.; Ter-Ovanesov, M.; Van der Velde, C.; Memo, M.; Castelli, F.; Pecorelli, S.; Detogni, C.; Kodera, Y.; De Manzoni, G.
Article Title: Follow-up after gastrectomy for cancer: The Charter Scaligero Consensus Conference
Abstract: Purpose: Presently, there is no scientific evidence supporting a definite role for follow-up after gastrectomy for cancer, and clinical practices are quite different around the globe. The aim of this consensus conference was to present an ideal prototype of follow-up after gastrectomy for cancer, based on shared experiences and taking into account the need to rationalize the diagnostic course without losing the possibility of detecting local recurrence at a potentially curable stage. Methods: On June 19–22, 2013 in Verona (Italy), during the 10th International Gastric Cancer Congress (IGCC) of the International Gastric Cancer Association, a consensus meeting was held, concluding a 6-month, Web-based, consensus conference entitled “Rationale of oncological follow-up after gastrectomy for cancer.” Results: Forty-eight experts, with a geographical distribution reflecting different health cultures worldwide, participated in the consensus conference, and 39 attended the consensus meeting. Six statements were finally approved, displayed in a plenary session and signed by the vast majority of the 10th IGCC participants. These statements are attached as an annex to the Charter Scaligero on Gastric Cancer. Conclusion: After gastrectomy for cancer, oncological follow-up should be offered to patients; it should be tailored to the stage of the disease, mainly based on cross-sectional imaging, and should be discontinued after 5 years. © 2015, The International Gastric Cancer Association and The Japanese Gastric Cancer Association.
Keywords: cancer survival; cancer surgery; survival rate; review; cancer recurrence; chemotherapy; cancer staging; follow up; cancer diagnosis; clinical practice; patient monitoring; practice guideline; patient care; health care personnel; surgery; gastrectomy; stomach cancer; consensus development; health care delivery; medical expert; follow-up; gastric cancer; italy; tumor markers; prognosis; human; priority journal; cross-sectional imaging; upper gastrointestinal tract endoscopy
Journal Title: Gastric Cancer
Volume: 19
Issue: 1
ISSN: 1436-3291
Publisher: Springer  
Date Published: 2016-01-01
Start Page: 15
End Page: 20
Language: English
DOI: 10.1007/s10120-015-0513-0
PROVIDER: scopus
PUBMED: 26140915
PMCID: PMC4890702
DOI/URL:
Notes: Review -- Export Date: 3 February 2016 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vivian Strong
    264 Strong
  2. Daniel Coit
    542 Coit